Target intelligence / Profile preview

Streptococcal pyrogenic exotoxin B (SpeB)

Target
SpeB
Molecular classification
Enzyme, Cysteine protease, Secreted virulence factor, Papain-like protease family
01

Overview

Streptococcal pyrogenic exotoxin B (SpeB), also known as streptococcal cysteine protease, is a secreted enzyme produced by Streptococcus pyogenes. It is a member of the papain-like family of cysteine proteases and is a major virulence factor implicated in invasive diseases such as necrotizing fasciitis. SpeB is synthesized as an inactive zymogen that is converted to its active protease form by autolytic cleavage. It cleaves a broad spectrum of host and bacterial proteins, facilitating tissue invasion, immune evasion, and pathology. Structurally, SpeB is a distant homolog of papain and cathepsins, but it forms a unique class among prokaryotic proteases. Its notable features include a non-canonical catalytic triad and the presence of an integrin-binding RGD motif, which may further contribute to its pathogenesis[1][2][8][9].

Other names
Streptococcal cysteine proteaseStreptococcal pyrogenic exotoxin BSCPSpeB
02

Mechanism of action

Inhibition of protease active site (cysteine protease inhibitors binding to catalytic cysteine)

03

Biological functions

Proteolysis of host and bacterial proteinsVirulence and tissue invasionImmune evasionDegradation of extracellular matrix components
04

Disease associations

InfectionVirulence factor in Streptococcus pyogenes (Group A Streptococcus)
05

Safety considerations

Potential for tissue destruction and immune evasionTargeting may affect host protease systems due to similarity to papain family enzymes
06

Interacting drugs

Z-LVG-CHN2 (inhibitor)

2 more in the full profile.

07

Biomarkers

Elevated SpeB expression or activity as a marker of severe group A streptococcal infection

Beyond the preview

Go deeper on Streptococcal pyrogenic exotoxin B (SpeB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcal pyrogenic exotoxin B (SpeB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call